Market Research Logo

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Irreversible Electroporation Ablators Market 2018, Forecast to 2023

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Irreversible Electroporation Ablators Market 2018, Forecast to 2023

Irreversible electroporation is a soft tissue ablation technique using ultra short but strong electrical fields to create permanent and hence lethal Nano pores in the cell membrane, to disrupt the cellular homeostasis. The resulting cell death results from apoptosis and not necrosis as in all other thermal or radiation based ablation techniques. The main use of IRE lies in tumor ablation in regions where precision and conservation of the extracellular matrix, blood flow and nerves are of importance. The technique is in an experimental stage and has not been approved for use outside of clinical trials. IRE is used in the NanoKnife System.

Scope of the Report:
This report focuses on the Irreversible Electroporation Ablators in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
At present, global economy is fluctuant, and most countries take measures to stimulate the economy, especially in Japan, Europe, Australia and the resources providing countries, like Russia, Middle East, Brazil etc. In many fields, China is the largest consumer, but in the past several years, China's economic growth slows .The China government is reforming the economic structure, to release energy of economy. USA economy is relatively stable with low-speed-growth, but in future, it also is full of risk. In RoA, the economy also is fluctuated the economic base is comparatively unsubstantial, due to the exchange fluctuations. In India, although many people look to further increase in India, but the economic aggregate is too low and the infrastructure is behindhand and inefficient. In a long term, India will keep a stable and low growth in economy, due to its economic structure and bureaucratic system.
The worldwide market for Irreversible Electroporation Ablators is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
AngioDynamics
Pulse Biosciences

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Generator
Part
Service

Market Segment by Applications, can be divided into
Liver
Pancreas
Prostate
Other

There are 15 Chapters to deeply display the global Irreversible Electroporation Ablators market.
Chapter 1, to describe Irreversible Electroporation Ablators Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Irreversible Electroporation Ablators, with sales, revenue, and price of Irreversible Electroporation Ablators, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Irreversible Electroporation Ablators, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Irreversible Electroporation Ablators market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Irreversible Electroporation Ablators sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


1 Market Overview
1.1 Irreversible Electroporation Ablators Introduction
1.2 Market Analysis by Type
1.2.1 Generator
1.2.2 Part
1.2.3 Service
1.3 Market Analysis by Applications
1.3.1 Liver
1.3.2 Pancreas
1.3.3 Prostate
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AngioDynamics
2.1.1 Business Overview
2.1.1.1 AngioDynamics Description
2.1.1.2 AngioDynamics Headquarter, Main Business and Finance Overview
2.1.2 AngioDynamics Irreversible Electroporation Ablators Product Introduction
2.1.2.1 Irreversible Electroporation Ablators Production Bases, Sales Regions and Major Competitors
2.1.2.2 Irreversible Electroporation Ablators Product Information
2.1.3 AngioDynamics Irreversible Electroporation Ablators Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 AngioDynamics Irreversible Electroporation Ablators Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global AngioDynamics Irreversible Electroporation Ablators Market Share in 2017
2.2 Pulse Biosciences
2.2.1 Business Overview
2.2.1.1 Pulse Biosciences Description
2.2.1.2 Pulse Biosciences Headquarter, Main Business and Finance Overview
2.2.2 Pulse Biosciences Irreversible Electroporation Ablators Product Introduction
2.2.2.1 Irreversible Electroporation Ablators Production Bases, Sales Regions and Major Competitors
2.2.2.2 Irreversible Electroporation Ablators Product Information
2.2.3 Pulse Biosciences Irreversible Electroporation Ablators Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Pulse Biosciences Irreversible Electroporation Ablators Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Pulse Biosciences Irreversible Electroporation Ablators Market Share in 2017
3 Global Irreversible Electroporation Ablators Market Competition, by Manufacturer
3.1 Global Irreversible Electroporation Ablators Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Irreversible Electroporation Ablators Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Irreversible Electroporation Ablators Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Irreversible Electroporation Ablators Manufacturer Market Share in 2017
3.4.2 Top 5 Irreversible Electroporation Ablators Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Irreversible Electroporation Ablators Market Analysis by Regions
4.1 Global Irreversible Electroporation Ablators Sales, Revenue and Market Share by Regions
4.1.1 Global Irreversible Electroporation Ablators Sales by Regions (2013-2018)
4.1.2 Global Irreversible Electroporation Ablators Revenue by Regions (2013-2018)
4.2 North America Irreversible Electroporation Ablators Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Irreversible Electroporation Ablators Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Irreversible Electroporation Ablators Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Irreversible Electroporation Ablators Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Irreversible Electroporation Ablators Sales, Revenue and Growth Rate (2013-2018)
5 North America Irreversible Electroporation Ablators by Countries, Type, Application and Manufacturers
5.1 North America Irreversible Electroporation Ablators Sales, Revenue and Market Share by Countries
5.1.1 North America Irreversible Electroporation Ablators Sales by Countries (2013-2018)
5.1.2 North America Irreversible Electroporation Ablators Revenue by Countries (2013-2018)
5.1.3 United States Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
5.1.4 Canada Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
5.1.5 Mexico Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
5.2 North America Irreversible Electroporation Ablators Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Irreversible Electroporation Ablators Sales by Manufacturers (2016-2017)
5.2.2 North America Irreversible Electroporation Ablators Revenue by Manufacturers (2016-2017)
5.3 North America Irreversible Electroporation Ablators Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Irreversible Electroporation Ablators Sales and Sales Share by Type (2013-2018)
5.3.2 North America Irreversible Electroporation Ablators Revenue and Revenue Share by Type (2013-2018)
5.4 North America Irreversible Electroporation Ablators Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Irreversible Electroporation Ablators Sales and Sales Share by Application (2013-2018)
5.4.2 North America Irreversible Electroporation Ablators Revenue and Revenue Share by Application (2013-2018)
6 Europe Irreversible Electroporation Ablators by Countries, Type, Application and Manufacturers
6.1 Europe Irreversible Electroporation Ablators Sales, Revenue and Market Share by Countries
6.1.1 Europe Irreversible Electroporation Ablators Sales by Countries (2013-2018)
6.1.2 Europe Irreversible Electroporation Ablators Revenue by Countries (2013-2018)
6.1.3 Germany Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
6.1.4 UK Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
6.1.5 France Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
6.1.6 Russia Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
6.1.7 Italy Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
6.2 Europe Irreversible Electroporation Ablators Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Irreversible Electroporation Ablators Sales by Manufacturers (2016-2017)
6.2.2 Europe Irreversible Electroporation Ablators Revenue by Manufacturers (2016-2017)
6.3 Europe Irreversible Electroporation Ablators Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Irreversible Electroporation Ablators Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Irreversible Electroporation Ablators Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Irreversible Electroporation Ablators Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Irreversible Electroporation Ablators Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Irreversible Electroporation Ablators Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Irreversible Electroporation Ablators by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Irreversible Electroporation Ablators Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Irreversible Electroporation Ablators Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Irreversible Electroporation Ablators Revenue by Countries (2013-2018)
7.1.3 China Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
7.1.4 Japan Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
7.1.5 Korea Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
7.1.6 India Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Irreversible Electroporation Ablators Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Irreversible Electroporation Ablators Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Irreversible Electroporation Ablators Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Irreversible Electroporation Ablators Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Irreversible Electroporation Ablators Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Irreversible Electroporation Ablators Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Irreversible Electroporation Ablators Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Irreversible Electroporation Ablators Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Irreversible Electroporation Ablators Revenue and Revenue Share by Application (2013-2018)
8 South America Irreversible Electroporation Ablators by Countries, Type, Application and Manufacturers
8.1 South America Irreversible Electroporation Ablators Sales, Revenue and Market Share by Countries
8.1.1 South America Irreversible Electroporation Ablators Sales by Countries (2013-2018)
8.1.2 South America Irreversible Electroporation Ablators Revenue by Countries (2013-2018)
8.1.3 Brazil Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
8.1.4 Argentina Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
8.1.5 Colombia Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
8.2 South America Irreversible Electroporation Ablators Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Irreversible Electroporation Ablators Sales by Manufacturers (2016-2017)
8.2.2 South America Irreversible Electroporation Ablators Revenue by Manufacturers (2016-2017)
8.3 South America Irreversible Electroporation Ablators Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Irreversible Electroporation Ablators Sales and Sales Share by Type (2013-2018)
8.3.2 South America Irreversible Electroporation Ablators Revenue and Revenue Share by Type (2013-2018)
8.4 South America Irreversible Electroporation Ablators Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Irreversible Electroporation Ablators Sales and Sales Share by Application (2013-2018)
8.4.2 South America Irreversible Electroporation Ablators Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Irreversible Electroporation Ablators by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Irreversible Electroporation Ablators Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Irreversible Electroporation Ablators Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Irreversible Electroporation Ablators Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
9.1.4 UAE Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
9.1.5 Egypt Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
9.1.7 South Africa Irreversible Electroporation Ablators Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Irreversible Electroporation Ablators Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Irreversible Electroporation Ablators Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Irreversible Electroporation Ablators Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Irreversible Electroporation Ablators Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Irreversible Electroporation Ablators Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Irreversible Electroporation Ablators Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Irreversible Electroporation Ablators Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Irreversible Electroporation Ablators Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Irreversible Electroporation Ablators Revenue and Revenue Share by Application (2013-2018)
10 Global Irreversible Electroporation Ablators Market Segment by Type
10.1 Global Irreversible Electroporation Ablators Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Irreversible Electroporation Ablators Sales and Market Share by Type (2013-2018)
10.1.2 Global Irreversible Electroporation Ablators Revenue and Market Share by Type (2013-2018)
10.2 Generator Sales Growth and Price
10.2.1 Global Generator Sales Growth (2013-2018)
10.2.2 Global Generator Price (2013-2018)
10.3 Part Sales Growth and Price
10.3.1 Global Part Sales Growth (2013-2018)
10.3.2 Global Part Price (2013-2018)
10.4 Service Sales Growth and Price
10.4.1 Global Service Sales Growth (2013-2018)
10.4.2 Global Service Price (2013-2018)
11 Global Irreversible Electroporation Ablators Market Segment by Application
11.1 Global Irreversible Electroporation Ablators Sales Market Share by Application (2013-2018)
11.2 Liver Sales Growth (2013-2018)
11.3 Pancreas Sales Growth (2013-2018)
11.4 Prostate Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Irreversible Electroporation Ablators Market Forecast (2018-2023)
12.1 Global Irreversible Electroporation Ablators Sales, Revenue and Growth Rate (2018-2023)
12.2 Irreversible Electroporation Ablators Market Forecast by Regions (2018-2023)
12.2.1 North America Irreversible Electroporation Ablators Market Forecast (2018-2023)
12.2.2 Europe Irreversible Electroporation Ablators Market Forecast (2018-2023)
12.2.3 Asia-Pacific Irreversible Electroporation Ablators Market Forecast (2018-2023)
12.2.4 South America Irreversible Electroporation Ablators Market Forecast (2018-2023)
12.2.5 Middle East and Africa Irreversible Electroporation Ablators Market Forecast (2018-2023)
12.3 Irreversible Electroporation Ablators Market Forecast by Type (2018-2023)
12.3.1 Global Irreversible Electroporation Ablators Sales Forecast by Type (2018-2023)
12.3.2 Global Irreversible Electroporation Ablators Market Share Forecast by Type (2018-2023)
12.4 Irreversible Electroporation Ablators Market Forecast by Application (2018-2023)
12.4.1 Global Irreversible Electroporation Ablators Sales Forecast by Application (2018-2023)
12.4.2 Global Irreversible Electroporation Ablators Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report